Determining the extent to which delayed‐enhancement images reflect the partition‐coefficient of Gd‐DTPA in canine studies of reperfused and unreperfused myocardial infarction

MRI after a constant infusion (CI) of Gd‐DTPA has been used to identify the extent of myocardial infarction (MI). However, Gd‐DTPA‐enhanced “viability” imaging is more commonly performed with a bolus (for “delayed‐enhancement” (DE) imaging). This study sought to determine how image delay time and time postinfarction influence the assessment of necrosis by DE. Both infusion and DE imaging was performed in dogs with reperfused (N = 6) or unreperfused (N = 4) MI. Estimates of the partition‐coefficient of Gd‐DTPA (λ) with DE were compared with those calculated after 60 min of infusion, and the comparisons were repeated until 4 (reperfused) or 8 (unreperfused) weeks postinfarction. In reperfused animals, the concordance (Rc) between DE and infusion estimates of λ was > 0.90 for most image delays > 8 min postinjection, for day 0 through week 3, with Rc at day 0 greater than at week 4 (P = 0.022). In unreperfused animals, there was an interaction between image delay time and time postinfarction (P < 0.001): Rc > 0.90 corresponded to longer image delays at week 1 than at weeks 4–8. Therefore, when image delays are selected appropriately, DE images can strongly reflect λ and identify irreversibly injured myocardium. Magn Reson Med 52:1069–1079, 2004. © 2004 Wiley‐Liss, Inc.

[1]  Jeroen J. Bax,et al.  Assessment of tissue viability: clinical demand and problems. , 1998, European heart journal.

[2]  J Sykes,et al.  Assessment of myocardial viability using MRI during a constant infusion of Gd‐DTPA: Further studies at early and late periods of reperfusion , 1999, Magnetic resonance in medicine.

[3]  R. Kim,et al.  Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function , 2001, Circulation.

[4]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[5]  R. Judd,et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.

[6]  R. Muthupillai,et al.  Assessing Myocardial Viability and Infarct Transmurality With Left Ventricular Electromechanical Mapping in Patients With Stable Coronary Artery Disease: Validation by Delayed-Enhancement Magnetic Resonance Imaging , 2002, Circulation.

[7]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[8]  K. Weber,et al.  Infarct scar: a dynamic tissue. , 2000, Cardiovascular research.

[9]  F. Prato,et al.  The assessment of myocardial viability: a review of current diagnostic imaging approaches. , 2002, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[10]  F. Prato,et al.  Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine , 1993, Magnetic resonance in medicine.

[11]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.

[12]  F. Prato,et al.  Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  F. Prato,et al.  Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd‐DTPA: Kinetic modeling in canine ischemic disease , 1992, Magnetic resonance in medicine.

[14]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[15]  K A Langmack,et al.  A general method for the measurement of radionuclide mixtures , 1992 .

[16]  Edwin Wu,et al.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.

[17]  R. Kim,et al.  Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.

[18]  J Sykes,et al.  Myocardial viability imaging using Gd‐DTPA: Physiological modeling of infarcted myocardium, and impact on injection strategy and imaging time , 2002, Magnetic resonance in medicine.

[19]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.

[20]  T K Foo,et al.  Improved ejection fraction and flow velocity estimates with use of view sharing and uniform repetition time excitation with fast cardiac techniques. , 1995, Radiology.

[21]  J. Oshinski,et al.  Imaging Time After Gd-DTPA Injection Is Critical in Using Delayed Enhancement to Determine Infarct Size Accurately With Magnetic Resonance Imaging , 2001, Circulation.

[22]  C. Lorenz,et al.  Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. , 2001, Radiology.

[23]  F. Prato,et al.  The determination of myocardial viability using Gd‐DTPA in a canine model of acute myocardial ischemia and reperfusion , 1996, Magnetic resonance in medicine.

[24]  K. Weber,et al.  Factors associated with reactive and reparative fibrosis of the myocardium. , 1992, Basic research in cardiology.

[25]  J Sykes,et al.  Contrast‐enhanced MRI for the assessment of myocardial viability after permanent coronary artery occlusion , 2000, Magnetic resonance in medicine.

[26]  Katherine C. Wu,et al.  Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction , 2002, Circulation.

[27]  E. McVeigh,et al.  Phase‐sensitive inversion recovery for detecting myocardial infarction using gadolinium‐delayed hyperenhancement † , 2002, Magnetic resonance in medicine.

[28]  L. Lin,et al.  A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.

[29]  B. Schnackenburg,et al.  Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography , 2002, Circulation.

[30]  Sebastian Flacke,et al.  Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. , 2003, Radiology.

[31]  R. Kim,et al.  Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. , 2000, Journal of the American College of Cardiology.

[32]  E. Fleck,et al.  Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[33]  R. Willenheimer.  Left ventricular remodelling and dysfunction. Can the process be prevented? , 2000, International journal of cardiology.

[34]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.